GlaxoSmithKline   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Mexico City Mexico (1982)

Organization Overview

First Clinical Trial
1990
NCT01536561
First Marketed Drug
1982
methoxamine (vasoxyl)
First NDA Approval
1985
bupropion (wellbutrin)
Last Known Activity
2022

Timeline

NOW
  • Now